SecSonar.com

RxSight, Inc. (RXST)

RxSight, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

RxSight, Inc. (RXST) is a Medical - Devices company based in US with a market capitalization of $228.9M. Revenue declined 3.9% year-over-year and free cash flow was negative at -$19.3M. This page tracks RXST's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 498 employees · IPO Jul 30, 2021

Valuation

Valuation & price

$5.68 · as of May 17, 2026 · -56.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.83

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$12.76$8.68$4.59Jul 25Dec 25Jul 26Jul 7, 25$12.43Jul 9, 25$7.95Jul 11, 25$8.00Jul 15, 25$7.45Jul 17, 25$7.38Jul 21, 25$7.35Jul 23, 25$7.90Jul 25, 25$7.97Jul 29, 25$7.83Jul 31, 25$7.78Aug 4, 25$7.92Aug 6, 25$7.55Aug 11, 25$6.65Aug 13, 25$8.31Aug 15, 25$8.43Aug 19, 25$8.81Aug 21, 25$8.73Aug 25, 25$8.61Aug 27, 25$8.55Aug 29, 25$9.04Sep 3, 25$8.89Sep 5, 25$8.89Sep 9, 25$9.78Sep 11, 25$9.42Sep 16, 25$9.08Sep 18, 25$9.49Sep 22, 25$9.52Sep 24, 25$9.18Sep 26, 25$9.03Sep 30, 25$8.99Oct 2, 25$8.56Oct 6, 25$8.49Oct 8, 25$8.21Oct 10, 25$7.51Oct 14, 25$7.74Oct 16, 25$8.48Oct 21, 25$8.71Oct 23, 25$8.43Oct 27, 25$8.66Oct 29, 25$8.43Oct 31, 25$8.79Nov 4, 25$9.00Nov 6, 25$8.61Nov 10, 25$10.11Nov 12, 25$10.01Nov 14, 25$9.73Nov 18, 25$9.60Nov 20, 25$8.95Nov 25, 25$10.67Nov 28, 25$11.42Dec 2, 25$11.76Dec 4, 25$12.49Dec 8, 25$12.56Dec 10, 25$12.59Dec 12, 25$12.62Dec 16, 25$12.76Dec 18, 25$12.31Dec 22, 25$12.23Dec 24, 25$11.46Dec 29, 25$10.75Jan 2, 26$10.38Jan 6, 26$9.99Jan 8, 26$9.57Jan 12, 26$10.09Jan 14, 26$9.67Jan 16, 26$9.81Jan 21, 26$9.95Jan 23, 26$9.51Jan 27, 26$9.22Jan 29, 26$8.91Feb 2, 26$8.83Feb 4, 26$7.94Feb 9, 26$8.26Feb 11, 26$8.03Feb 13, 26$8.04Feb 18, 26$8.53Feb 20, 26$8.63Feb 24, 26$8.94Feb 26, 26$7.92Mar 2, 26$7.61Mar 4, 26$7.93Mar 6, 26$7.69Mar 10, 26$7.51Mar 12, 26$7.64Mar 17, 26$7.56Mar 19, 26$6.74Mar 23, 26$6.39Mar 25, 26$6.59Mar 27, 26$6.26Mar 31, 26$6.16Apr 2, 26$6.64Apr 7, 26$6.76Apr 9, 26$6.77Apr 13, 26$7.05Apr 15, 26$7.22Apr 17, 26$7.61Apr 22, 26$7.40Apr 24, 26$7.25Apr 28, 26$7.17Apr 30, 26$7.07May 4, 26$7.38May 6, 26$6.78May 8, 26$5.85May 12, 26$5.52May 14, 26$5.63May 18, 26$6.00May 20, 26$6.16May 22, 26$6.09May 28, 26$5.59Jun 1, 26$5.24Jun 3, 26$4.79Jun 5, 26$5.00Jun 9, 26$4.91Jun 11, 26$4.80Jun 15, 26$4.79Jun 17, 26$4.59Jun 22, 26$4.96Jun 24, 26$5.31Jun 26, 26$5.36Jul 2, 26$5.61
$4.5952-week range$13.09
Loading valuation history…

Fundamentals

Key fundamentals

$228.9M

Market cap

-3.9%

Revenue growth (YoY)

76.6%

Gross margin

-$19.3M

Free cash flow (USD)

-$217.1M

Net debt

Net cash position

5.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$2.2MFY 2020$14.7MFY 2021$22.6MFY 2022$49.0MFY 2023$89.1MFY 2024$139.9MFY 2025$134.5M
$2.2M$134.5M

Free cash flow by year

2019 → 2025

FY 2019$-44.7MFY 2020$-37.7MFY 2021$-46.6MFY 2022$-61.2MFY 2023$-46.4MFY 2024$-22.4MFY 2025$-19.3M
-$44.7M-$19.3M

Gross margin by year

2021 → 2025

FY 202120.0%FY 202243.5%FY 202360.4%FY 202470.7%FY 202576.6%
20.0%76.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 16, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is RxSight, Inc.'s market cap?

RxSight, Inc. (RXST) has a market capitalization of $228.9M.

What is RXST's P/E ratio?

A meaningful P/E ratio is not available for RXST — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is RXST's price-to-book (P/B) ratio?

RXST trades at 0.83 times book value per share.

Are insiders buying RXST stock?

SEC Form 4 filings show no open-market insider buys at RxSight, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

TMCI

Treace Medical Concepts, Inc.

$218.9M

PROF

Profound Medical Corp.

$207.1M

ANIK

Anika Therapeutics, Inc.

$196.4M

SGHT

Sight Sciences, Inc.

$270.1M

SENS

Senseonics Holdings, Inc.

$280.3M

INGN

Inogen, Inc.

$177.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.